Nucleotide sequence of exons 5 to 9 of the p53 tumour-suppressor gene of the horse (Equus caballus).

The research article discusses the DNA sequencing of a critical part (exons 5 to 9) in the gene named p53, which is a tumor suppressor in the horse genome.

Objective of the Study

• The objective of the study was to perform Polymerase Chain Reaction (PCR) amplification, cloning, and sequencing of an evolutionarily conserved 1.3 kilobase (kb) fragment of the horse p53 gene, which corresponds to exons 5 to 9 along with the introns in between.

Methodology

• The researchers first isolated a 1.3 kb fragment of the horse genome. The fragment corresponds to the part of the p53 gene that encodes exons 5 to 9 as well as the intervening introns.
• Next, they used Polymerase Chain Reaction (PCR), a technique that enables the amplification of a specific DNA segment, to increase the number of copies of the isolated fragment.
• They then cloned or made copies of the amplified DNA segment.
• Finally, they determined the nucleotide sequence or the precise order of nucleotides within a DNA molecule of the cloned DNA fragment.

Findings

• The study showed that the nucleotide sequence of the horse p53 fragment, as well as the predicted amino acid sequence, exhibited a high degree of similarity, also known as homology, with the human and donkey p53 sequences.
• This finding indicates that the structure of this part of the p53 gene is highly conserved, meaning it has changed little over evolutionary time.

Significance

• The results of this study contribute to our understanding of the genetic basis of tumor suppression in horses, which could have implications for developing strategies for cancer prevention and treatment in this species.
• The scientific knowledge gained from this study is also beneficial for comparative genomics, as understanding the similarities and differences in the structure and function of p53 across different species can provide insights into its role in tumor suppression in humans.